Suppr超能文献

常规膀胱镜下取出支架期间无需使用抗生素:加州大学圣地亚哥分校的一项随机对照试验

Antibiotics are not necessary during routine cystoscopic stent removal: A randomized controlled trial at UC San Diego.

作者信息

Bradshaw Aaron W, Pe Mark, Bechis Seth K, Dipina Thomas, Zupkas Paul, Abbott Joel E, Papagiannopoulos Dimitri, Cobb Kaitlan D, Sur Roger L

机构信息

UC San Diego Health, San Diego, CA, USA.

Genesis Healthcare, San Diego, CA, USA.

出版信息

Urol Ann. 2020 Oct-Dec;12(4):373-378. doi: 10.4103/UA.UA_130_19. Epub 2020 Oct 15.

Abstract

INTRODUCTION

Current American Urological Association (AUA) Best Practice Statement recommends antibiotic prophylaxis for cystoscopy with manipulation, including stent removal; although no Level 1b trials explicitly address prophylaxis for stent removal. We sought to determine the efficacy of prophylactic antibiotics to prevent infectious complications after stent removal.

MATERIALS AND METHODS

Following institutional review board approval, patients undergoing removal of ureteral stent placed during stone surgery were recruited from July 2016 to March 2019. Patients were recruited at the time of stent removal and randomized to treatment (single dose 500 mg oral ciprofloxacin) or control group (no antibiotics). Telephone contact was attempted within 14 days of stent removal to assess for urinary tract infection (UTI) symptoms, antibiotic prescriptions, or Emergency Department visits. was UTI within 1 month of stent removal - defined by irritative voiding symptoms, fever or abdominal pain associated with positive urine culture (Ucx) (>100k colony-forming units/mL).

RESULTS

Seventy-seven patients were enrolled, with 58 meeting final inclusion criteria for the analysis (33 treatment, 25 controls). No differences were seen with clinical and demographic variables, except a higher body mass index in the treatment group ( = 0.007). Positive Ucx rate before stone surgery (16.7% vs. 11.8%, = 0.819) and at the time of stent removal (16.0% vs. 11.1%, = 0.648) was not significantly different in treatment versus control groups, respectively. : No patients in either cohort developed symptomatic culture-diagnosed UTI within 1 month of stent removal. Of patients with documented phone follow-up (treatment = 29, control = 22), only one patient (control) reported any positive response on phone survey.

CONCLUSIONS

We found a low infectious complication rate regardless of antibiotic prophylaxis use during cystoscopic stent removal. The necessity of antibiotics during routine cystoscopic stent removal warrants possible reevaluation of the AUA best practice statement.

摘要

引言

美国泌尿外科学会(AUA)当前的最佳实践声明建议,对于包括取出支架在内的有操作的膀胱镜检查,应进行抗生素预防;尽管尚无1b级试验明确针对支架取出的预防措施。我们试图确定预防性使用抗生素预防支架取出后感染并发症的疗效。

材料与方法

经机构审查委员会批准,2016年7月至2019年3月招募了在结石手术期间置入输尿管支架后接受支架取出的患者。在支架取出时招募患者,并随机分为治疗组(单剂量500mg口服环丙沙星)或对照组(不使用抗生素)。在支架取出后14天内尝试电话联系,以评估是否有尿路感染(UTI)症状、抗生素处方或急诊就诊情况。支架取出后1个月内的UTI定义为:伴有刺激性排尿症状、发热或与尿培养阳性(Ucx)(>100k菌落形成单位/mL)相关的腹痛。

结果

共纳入77例患者,其中58例符合最终纳入分析标准(治疗组33例,对照组25例)。除治疗组的体重指数较高外(P = 0.007),临床和人口统计学变量未见差异。治疗组与对照组在结石手术前(16.7%对11.8%,P = 0.819)和支架取出时(16.0%对11.1%,P = 0.648)的Ucx阳性率无显著差异。结果:两组均无患者在支架取出后1个月内发生有症状的培养确诊UTI。在有记录的电话随访患者中(治疗组n = 29,对照组n = 22),只有1例患者(对照组)在电话调查中报告有任何阳性反应。

结论

我们发现,无论在膀胱镜下取出支架期间是否使用抗生素预防,感染并发症发生率都很低。常规膀胱镜下取出支架时使用抗生素的必要性可能需要重新评估AUA最佳实践声明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76f4/7992522/2d7e2c349589/UA-12-373-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验